Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Imutec Pharma begins preclinical development of antitumor agents

March 27, 1998

Disappointing preliminary phase III results for lisofylline in BMT

March 27, 1998

FDA advisory committee recommends Taxol for new indications

March 27, 1998

New drug therapy option for colonic polyps described

March 27, 1998

Differentiation-inducing retinoyloxy(substituted)alkylene butyrates from Bar-Ilan

March 26, 1998

Northwest Hospital's prostate cancer vaccine shows promise in phase I/II; new trial sites added

March 26, 1998

Angiogenesis-inhibitory monokine available for licensing from NIH

March 25, 1998

New agents for PDT reported by Yeda

March 25, 1998

New antitumor agents discovered by Toagosei

March 25, 1998

CTL establishes antigen discovery collaboration with University of Tubingen

March 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...